新抑癌基因GPD1在结肠癌细胞HCT-8中的作用及其预后潜力研究

doi:10.3969/j.issn.1006-7795.2019.04.027

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (4): 646-651.doi: 10.3969/j.issn.1006-7795.2019.04.027

新抑癌基因GPD1在结肠癌细胞HCT-8中的作用及其预后潜力研究

闵力, 李恒存, 郭庆东, 王星宇, 张澍田

首都医科大学附属北京友谊医院消化分中心国家消化系统疾病临床医学研究中心消化疾病癌前病变北京市重点实验室北京消化中心, 北京 100050

收稿日期:2019-03-15 出版日期:2019-07-21 发布日期:2019-07-19
通讯作者: 张澍田 E-mail:zhangshutian@ccmu.edu.cn
基金资助:
北京市医院管理中心消化内科学科协同发展中心重点项目（XXZ01）。

GPD1 represses colon cancer cell HCT-8 growth and indicates a favorable prognosis in colorectal cancer

Min Li, Li Hengcun, Guo Qingdong, Wang Xingyu, Zhang Shutian

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University;National Clinical Research Center for Digestive Disease;Beijing Digestive Disease Center;Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Beijing 100050, China

Received:2019-03-15 Online:2019-07-21 Published:2019-07-19
Supported by:
This study was supported by Digestive Medical Coordinated Development Center of Beijing Hospital Authority (XXZ01).

摘要/Abstract

摘要： 目的探究新抑癌基因甘油-3-磷酸脱氢酶1（glycerol-3-phosphate dehydrogenase 1，GPD1）在结肠癌发生、发展中的作用及其与临床预后的关系。方法应用HCT-8结肠癌细胞系，以siRNA干扰GPD1表达后进行细胞功能实验，分别以MTS实验与集落形成实验检测细胞增生活力与集落形成能力，以划痕试验、Transwell实验探究GPD1对HCT-8细胞系迁移能力的影响。对TCGA数据库进行生物信息学分析，探究GPD1表达水平与结直肠癌患者临床预后的关系，并明确GPD1低表达与其编码基因甲基化之间的关系。结果干扰GPD1基因表达后，HCT-8细胞增生活力明显增强，重复实验差异具有统计学意义（P<0.01）；集落形成实验结果显示，GPD1干扰后的HCT-8细胞集落数目增多且集落直径增大，差异具有统计学意义（P<0.01）。划痕实验与Transwell实验结果显示，敲低GPD1表达的HCT-8细胞迁移能力无显著变化，表明GPD1对结肠癌细胞迁移能力无影响。生物信息学分析结果显示，GPD1低表达的结直肠癌患者总存活率（χ²=4.1，P=0.040）及无病存活率（χ²=13.2，P<0.000 1）均明显低于GPD1高表达患者，且GPD1低表达水平是结直肠癌预后不良的独立风险因素（P<0.05）。甲基化分析结果显示，结直肠癌组织中GPD1低表达与其编码基因高甲基化呈负相关（P<0.05）。结论 GPD1在结肠癌中发挥抑制细胞增生与集落形成的作用，且GPD1低表达是结直肠癌患者不良预后的独立预测因素。

关键词: 结肠癌, GPD1, 细胞增生, 预后

Abstract: Objective To explore the role of glycerol-3-phosphate dehydrogenase 1 (GPD1) in the development of colorectal cancer and its relationship with clinical prognosis. Methods HCT-8 colon cancer cell line was used in this study. Cell function experiments were performed after GPD1 expression knockdown by using siRNA. Cell proliferation activity and colony formation ability were detected by MTS assay and colony formation assay respectively. The migration ability was determined applying wound scratch assay and transwell assay. The bioinformatics analysis of the TCGA database explored the relationship between the expression level of GPD1 and the clinical prognosis of colorectal cancer patients. The relationship between the low expression of GPD1 in colorectal cancer and the methylation level of its coding gene was also explored. Results After interference of GPD1 gene expression by siRNA, the proliferation ability of HCT-8 cells was significantly enhanced (P<0.01). The results of colony formation experiments showed that the colony number and size of HCT-8 cell colonies significantly increased after GPD1 siRNA treatment (P<0.01). The results of the wound scratch test and transwell assay showed that there was no significant change in the migration ability of GPD1 knockdown HCT-8 cells, indicating that GPD1 had no effect on the migration ability of colon cancer cells. Bioinformatics analysis showed that the overall survival (χ²=4.1, P=0.040) and disease-free survival (χ²=13.2, P<0.000 1) of patients with low expression of GPD1 were significantly lower than those with high expression of GPD1. Also, low expression level of GPD1 was identified as an independent risk factor for poor prognosis of colorectal cancer (P<0.05). Methylation analysis showed that the low expression of GPD1 in colorectal cancer tissues was negatively correlated with hypermethylation of its coding gene (P<0.05). Conclusion GPD1 plays a role in inhibiting cell proliferation and colony formation in colon cancer, and low expression of GPD1 is an independent predictor of poor prognosis in patients with colorectal cancer.

Key words: colon cancer, GPD1, cell proliferation, prognosis

中图分类号:

R735.3⁺5

闵力, 李恒存, 郭庆东, 王星宇, 张澍田. 新抑癌基因GPD1在结肠癌细胞HCT-8中的作用及其预后潜力研究[J]. 首都医科大学学报, 2019, 40(4): 646-651.

Min Li, Li Hengcun, Guo Qingdong, Wang Xingyu, Zhang Shutian. GPD1 represses colon cancer cell HCT-8 growth and indicates a favorable prognosis in colorectal cancer[J]. Journal of Capital Medical University, 2019, 40(4): 646-651.

参考文献 18

[1]	Torre L A, Bray F, Siegel R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87-108.
[2]	Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132.
[3]	Sadanandam A, Lyssiotis C A, Homicsko K, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy[J]. Nat Med, 2013,19(5):619-625.
[4]	De Sousa E M F, Wang X, Jansen M, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions[J]. Nat Med, 2013,19(5):614-618.
[5]	Wu J W, Yang H, Wang S P, et al. Inborn errors of cytoplasmic triglyceride metabolism[J]. J Inherit Metab Dis, 2015,38(1):85-98.
[6]	Swierczynski J, Zabrocka L, Goyke E, et al. Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans[J]. Mol Cell Biochem, 2003,254(1-2):55-59.
[7]	Joshi M, Eagan J, Desai N K, et al. A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia[J]. Eur J Hum Genet, 2014,22(10):1229-1232.
[8]	Basel-Vanagaite L, Zevit N, Har Zahav A, et al. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1[J]. Am J Hum Genet, 2012,90(1):49-60.
[9]	Zhou C, Yu J, Wang M, et al. Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer[J]. Oncotarget, 2017,8(60):101309-101324.
[10]	Menaya J, Gonzalez-Manchon C, Parrilla R, et al. Molecular cloning, sequencing and expression of a cDNA encoding a human liver NAD-dependent alpha-glycerol-3-phosphate dehydrogenase[J]. Biochim Biophys Acta, 1995,1262(1):91-94.
[11]	Bestor T H, Edwards J R, Boulard M. Notes on the role of dynamic DNA methylation in mammalian development[J]. Proc Natl Acad Sci U S A, 2015,112(22):6796-6799.
[12]	Descotes F, Jezequel P, Spyratos F, et al. Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis:a multicentric 2004 national PHRC study[J]. Int J Oncol, 2012,41(1):92-104.
[13]	Hanahan D, Weinberg R A. Hallmarks of cancer:the next generation[J]. Cell, 2011,144(5):646-674.
[14]	Warburg O, Wind F, Negelein E. The metabolism of tumors in the body[J]. J Gen Physiol, 1927,8(6):519-530.
[15]	Vander Heiden M G, Cantley L C, Thompson C B. Understanding the Warburg effect:the metabolic requirements of cell proliferation[J]. Science, 2009,324(5930):1029-1033.
[16]	Hsu P P, Sabatini D M. Cancer cell metabolism:warburg and beyond[J]. Cell, 2008,134(5):703-707.
[17]	李晶, 黄三钱, 欧阳取长, 等. 三阴性与三阳性乳腺癌定量蛋白质组学和生物信息学比较研究[J]. 中华肿瘤防治杂志, 2016, 23(16):1053-1059.
[18]	Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas[J]. Gastroenterology, 2007,132(6):2208-2225.

新抑癌基因GPD1在结肠癌细胞HCT-8中的作用及其预后潜力研究

GPD1 represses colon cancer cell HCT-8 growth and indicates a favorable prognosis in colorectal cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 18

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王荣荣, 田俊萍. 急性冠脉综合征患者血清钙与心血管预后的关系[J]. 首都医科大学学报, 2023, 44(1): 154-160.
[2]	贾静, 陈文明, 李燕郴. 多发性骨髓瘤伴中枢侵犯临床特征及预后分析[J]. 首都医科大学学报, 2023, 44(1): 161-166.
[3]	于天宇, 姜世敏, 高红梅, 邹古明, 李文歌. 糖尿病肾病慢性肾脏病4期患者肾脏临床及病理因素与预后的关系[J]. 首都医科大学学报, 2022, 43(5): 707-712.
[4]	郭康林, 程一春, 葛树旺, 徐钢. IgA肾病国际风险预测工具在中国人群中的预测效果评价[J]. 首都医科大学学报, 2022, 43(5): 713-719.
[5]	谷强, 余孝君, 张津. 高龄与中低龄老年轻型缺血性脑卒中临床特点及预后分析[J]. 首都医科大学学报, 2022, 43(3): 474-479.
[6]	周巧云, 黄晓武, 夏恩兰, 赵玉婷, 黄睿. 子宫动脉栓塞后宫腔粘连的生殖结局分析[J]. 首都医科大学学报, 2022, 43(3): 490-494.
[7]	苗祖霈, 张迎花, 肖克令, 司瑾, 张浩宇, 李静. 肥胖程度对急性ST段抬高型心肌梗死患者预后的影响[J]. 首都医科大学学报, 2022, 43(2): 192-198.
[8]	孙婧, 史幼梧, 贾军, 杨颖, 孙志伟, 杜丰, 余靖, 肖艳洁, 张晓东. 血液炎症相关指标在晚期胰腺癌中的预后价值[J]. 首都医科大学学报, 2022, 43(2): 299-304.
[9]	刘洋, 吴玉梅, 何玥, 樊蓓, 王雁, 赵辉, 王明. ⅠB期子宫颈癌国际妇产科联盟2018新分期的合理性验证及评估[J]. 首都医科大学学报, 2021, 42(6): 1026-1032.
[10]	王莉, 张国军. 血清神经元特异性烯醇化酶与外伤性脑损伤患者及临床特征的关系[J]. 首都医科大学学报, 2021, 42(5): 715-720.
[11]	来璇, 张爱华. 代谢综合征对慢性肾脏病患者生存预后的影响[J]. 首都医科大学学报, 2021, 42(4): 609-614.
[12]	刘揆亮, 李楠杉, 吴静, 李文坤, 李倩, 王亚丹. NLE1在结肠癌中的表达及其对HT29细胞增殖凋亡的影响[J]. 首都医科大学学报, 2021, 42(3): 425-430.
[13]	王欣, 张俊璇, 高健, 石汉平. 免疫营养改善肿瘤患者预后[J]. 首都医科大学学报, 2020, 41(6): 1019-1024.
[14]	刘军, 曹庆飞, 叶雄俊, 陈伟男, 赵海岳, 佟明, 王银银, 黄晓波, 常智杰. CREPT在肾癌组织中的表达及其与预后的关系[J]. 首都医科大学学报, 2020, 41(4): 552-557.
[15]	吴西抗, 王跃, 贺慧颖. 上尿路尿路上皮癌Slit引导配体3的表达与临床病理特征以及预后的关系[J]. 首都医科大学学报, 2020, 41(3): 354-359.